世界の糖尿病性神経障害薬市場：市場規模・現状・予測

• 英文タイトル：Global Diabetic Neuropathy Drugs Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7093 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、糖尿病性神経障害薬のグローバル市場について調査・分析したレポートで、種類別（カルシウムチャンネルアルファ-2デルタリガンド、SNRIとTCA、その他）、用途別（病院、ドラッグストア、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・糖尿病性神経障害薬の世界市場規模 ・主要企業別市場シェア ・糖尿病性神経障害薬の世界市場規模：種類別（カルシウムチャンネルアルファ-2デルタリガンド、SNRIとTCA、その他） ・糖尿病性神経障害薬の世界市場規模：用途別（病院、ドラッグストア、その他） ・糖尿病性神経障害薬のアメリカ市場規模（種類別、用途別） ・糖尿病性神経障害薬のヨーロッパ市場規模（種類別、用途別） ・糖尿病性神経障害薬の中国市場規模（種類別、用途別） ・糖尿病性神経障害薬の日本市場規模（種類別、用途別） ・糖尿病性神経障害薬の東南アジア市場規模（種類別、用途別） ・糖尿病性神経障害薬のインド市場規模（種類別、用途別） ・糖尿病性神経障害薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・糖尿病性神経障害薬の世界市場予測（2019年-2025年） ・糖尿病性神経障害薬の地域別市場予測（2019年-2025年） ...

Diabetic neuropathies are nerve damaging disorders associated with diabetes mellitus. These conditions are thought to result from a diabetic microvascular injury involving small blood vessels that supply nerves (vasa nervorum) in addition to macrovascular conditions that can accumulate in diabetic neuropathy.In 2018, the global Diabetic Neuropathy Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Diabetic Neuropathy Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Neuropathy Drugs development in United States, Europe and China.

The key players covered in this study
Pfizer
Novartis
Johnson & Johnson
Eli Lilly
GlaxoSmithKline
Boehringer Ingelheim
Teva Pharmaceutical
Daiichi Sankyo
Astellas Pharma

Market segment by Type, the product can be split into
Calcium Channel Alpha-2 Delta Ligand
SNRIs and TCAs
Others

Market segment by Application, split into
Hospitals
Drug Stores
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Diabetic Neuropathy Drugs status, future forecast, growth opportunity, key market and key players.
To present the Diabetic Neuropathy Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Diabetic Neuropathy Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diabetic Neuropathy Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Calcium Channel Alpha-2 Delta Ligand
1.4.3 SNRIs and TCAs
1.4.4 Others
1.5 Market by Application
1.5.1 Global Diabetic Neuropathy Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Drug Stores
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Diabetic Neuropathy Drugs Market Size
2.2 Diabetic Neuropathy Drugs Growth Trends by Regions
2.2.1 Diabetic Neuropathy Drugs Market Size by Regions (2014-2025)
2.2.2 Diabetic Neuropathy Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Diabetic Neuropathy Drugs Market Size by Manufacturers
3.1.1 Global Diabetic Neuropathy Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Diabetic Neuropathy Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Diabetic Neuropathy Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Neuropathy Drugs Key Players Head office and Area Served
3.3 Key Players Diabetic Neuropathy Drugs Product/Solution/Service
3.4 Date of Enter into Diabetic Neuropathy Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Diabetic Neuropathy Drugs Market Size by Type (2014-2019)
4.2 Global Diabetic Neuropathy Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Diabetic Neuropathy Drugs Market Size (2014-2019)
5.2 Diabetic Neuropathy Drugs Key Players in United States
5.3 United States Diabetic Neuropathy Drugs Market Size by Type
5.4 United States Diabetic Neuropathy Drugs Market Size by Application

6 Europe
6.1 Europe Diabetic Neuropathy Drugs Market Size (2014-2019)
6.2 Diabetic Neuropathy Drugs Key Players in Europe
6.3 Europe Diabetic Neuropathy Drugs Market Size by Type
6.4 Europe Diabetic Neuropathy Drugs Market Size by Application

7 China
7.1 China Diabetic Neuropathy Drugs Market Size (2014-2019)
7.2 Diabetic Neuropathy Drugs Key Players in China
7.3 China Diabetic Neuropathy Drugs Market Size by Type
7.4 China Diabetic Neuropathy Drugs Market Size by Application

8 Japan
8.1 Japan Diabetic Neuropathy Drugs Market Size (2014-2019)
8.2 Diabetic Neuropathy Drugs Key Players in Japan
8.3 Japan Diabetic Neuropathy Drugs Market Size by Type
8.4 Japan Diabetic Neuropathy Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Diabetic Neuropathy Drugs Market Size (2014-2019)
9.2 Diabetic Neuropathy Drugs Key Players in Southeast Asia
9.3 Southeast Asia Diabetic Neuropathy Drugs Market Size by Type
9.4 Southeast Asia Diabetic Neuropathy Drugs Market Size by Application

10 India
10.1 India Diabetic Neuropathy Drugs Market Size (2014-2019)
10.2 Diabetic Neuropathy Drugs Key Players in India
10.3 India Diabetic Neuropathy Drugs Market Size by Type
10.4 India Diabetic Neuropathy Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Diabetic Neuropathy Drugs Market Size (2014-2019)
11.2 Diabetic Neuropathy Drugs Key Players in Central & South America
11.3 Central & South America Diabetic Neuropathy Drugs Market Size by Type
11.4 Central & South America Diabetic Neuropathy Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diabetic Neuropathy Drugs Introduction
12.1.4 Pfizer Revenue in Diabetic Neuropathy Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diabetic Neuropathy Drugs Introduction
12.2.4 Novartis Revenue in Diabetic Neuropathy Drugs Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diabetic Neuropathy Drugs Introduction
12.3.4 Johnson & Johnson Revenue in Diabetic Neuropathy Drugs Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diabetic Neuropathy Drugs Introduction
12.4.4 Eli Lilly Revenue in Diabetic Neuropathy Drugs Business (2014-2019)
12.4.5 Eli Lilly Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diabetic Neuropathy Drugs Introduction
12.5.4 GlaxoSmithKline Revenue in Diabetic Neuropathy Drugs Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Details
12.6.2 Company Description and Business Overview
12.6.3 Diabetic Neuropathy Drugs Introduction
12.6.4 Boehringer Ingelheim Revenue in Diabetic Neuropathy Drugs Business (2014-2019)
12.6.5 Boehringer Ingelheim Recent Development
12.7 Teva Pharmaceutical
12.7.1 Teva Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Diabetic Neuropathy Drugs Introduction
12.7.4 Teva Pharmaceutical Revenue in Diabetic Neuropathy Drugs Business (2014-2019)
12.7.5 Teva Pharmaceutical Recent Development
12.8 Daiichi Sankyo
12.8.1 Daiichi Sankyo Company Details
12.8.2 Company Description and Business Overview
12.8.3 Diabetic Neuropathy Drugs Introduction
12.8.4 Daiichi Sankyo Revenue in Diabetic Neuropathy Drugs Business (2014-2019)
12.8.5 Daiichi Sankyo Recent Development
12.9 Astellas Pharma
12.9.1 Astellas Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Diabetic Neuropathy Drugs Introduction
12.9.4 Astellas Pharma Revenue in Diabetic Neuropathy Drugs Business (2014-2019)
12.9.5 Astellas Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Diabetic Neuropathy Drugs Key Market Segments
Table Key Players Diabetic Neuropathy Drugs Covered
Table Global Diabetic Neuropathy Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Diabetic Neuropathy Drugs Market Size Market Share by Type 2014-2025
Figure Calcium Channel Alpha-2 Delta Ligand Figures
Table Key Players of Calcium Channel Alpha-2 Delta Ligand
Figure SNRIs and TCAs Figures
Table Key Players of SNRIs and TCAs
Figure Others Figures
Table Key Players of Others
Table Global Diabetic Neuropathy Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Drug Stores Case Studies
Figure Others Case Studies
Figure Diabetic Neuropathy Drugs Report Years Considered
Table Global Diabetic Neuropathy Drugs Market Size 2014-2025 (Million US$)
Figure Global Diabetic Neuropathy Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Diabetic Neuropathy Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Diabetic Neuropathy Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Diabetic Neuropathy Drugs Market Share by Regions 2014-2019
Figure Global Diabetic Neuropathy Drugs Market Share by Regions 2014-2019
Figure Global Diabetic Neuropathy Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Diabetic Neuropathy Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Diabetic Neuropathy Drugs Market Share by Manufacturers (2014-2019)
Figure Global Diabetic Neuropathy Drugs Market Share by Manufacturers in 2018
Table Global Diabetic Neuropathy Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Diabetic Neuropathy Drugs Product/Solution/Service
Table Date of Enter into Diabetic Neuropathy Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Diabetic Neuropathy Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Diabetic Neuropathy Drugs Market Size Share by Type (2014-2019)
Figure Global Diabetic Neuropathy Drugs Market Size Market Share by Type (2014-2019)
Table Global Diabetic Neuropathy Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Diabetic Neuropathy Drugs Market Size Share by Application (2014-2019)
Figure Global Diabetic Neuropathy Drugs Market Size Market Share by Application (2014-2019)
Figure Global Diabetic Neuropathy Drugs Revenue Market Share by Application in 2018
Figure United States Diabetic Neuropathy Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Diabetic Neuropathy Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Diabetic Neuropathy Drugs Market Share (2018-2019)
Table United States Diabetic Neuropathy Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Diabetic Neuropathy Drugs Market Share by Type (2014-2019)
Table United States Diabetic Neuropathy Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Diabetic Neuropathy Drugs Market Share by Application (2014-2019)
Figure Europe Diabetic Neuropathy Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Diabetic Neuropathy Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Diabetic Neuropathy Drugs Market Share (2018-2019)
Table Europe Diabetic Neuropathy Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Diabetic Neuropathy Drugs Market Share by Type (2014-2019)
Table Europe Diabetic Neuropathy Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Diabetic Neuropathy Drugs Market Share by Application (2014-2019)
Figure China Diabetic Neuropathy Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Diabetic Neuropathy Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Diabetic Neuropathy Drugs Market Share (2018-2019)
Table China Diabetic Neuropathy Drugs Market Size by Type (2014-20189) (Million US$)
Table China Diabetic Neuropathy Drugs Market Share by Type (2014-2019)
Table China Diabetic Neuropathy Drugs Market Size by Application (2014-2019) (Million US$)
Table China Diabetic Neuropathy Drugs Market Share by Application (2014-2019)
Figure Japan Diabetic Neuropathy Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Diabetic Neuropathy Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Diabetic Neuropathy Drugs Market Share (2018-2019)
Table Japan Diabetic Neuropathy Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Diabetic Neuropathy Drugs Market Share by Type (2014-2019)
Table Japan Diabetic Neuropathy Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Diabetic Neuropathy Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Diabetic Neuropathy Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Diabetic Neuropathy Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Diabetic Neuropathy Drugs Market Share (2018-2019)
Table Southeast Asia Diabetic Neuropathy Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Diabetic Neuropathy Drugs Market Share by Type (2014-2019)
Table Southeast Asia Diabetic Neuropathy Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Diabetic Neuropathy Drugs Market Share by Application (2014-2019)
Figure India Diabetic Neuropathy Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Diabetic Neuropathy Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Diabetic Neuropathy Drugs Market Share (2018-2019)
Table India Diabetic Neuropathy Drugs Market Size by Type (2014-2019) (Million US$)
Table India Diabetic Neuropathy Drugs Market Share by Type (2014-2019)
Table India Diabetic Neuropathy Drugs Market Size by Application (2014-2019) (Million US$)
Table India Diabetic Neuropathy Drugs Market Share by Application (2014-2019)
Figure Central & South America Diabetic Neuropathy Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Diabetic Neuropathy Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Diabetic Neuropathy Drugs Market Share (2018-2019)
Table Central & South America Diabetic Neuropathy Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Diabetic Neuropathy Drugs Market Share by Type (2014-2019)
Table Central & South America Diabetic Neuropathy Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Diabetic Neuropathy Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Diabetic Neuropathy Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Diabetic Neuropathy Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Diabetic Neuropathy Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Diabetic Neuropathy Drugs Business (2014-2019)
Table Novartis Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Diabetic Neuropathy Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Diabetic Neuropathy Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Diabetic Neuropathy Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Diabetic Neuropathy Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Diabetic Neuropathy Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Diabetic Neuropathy Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Diabetic Neuropathy Drugs Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Diabetic Neuropathy Drugs Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Diabetic Neuropathy Drugs Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Diabetic Neuropathy Drugs Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Diabetic Neuropathy Drugs Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Diabetic Neuropathy Drugs Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Diabetic Neuropathy Drugs Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Diabetic Neuropathy Drugs Business (2014-2019)
Table Astellas Pharma Recent Development
Table Global Diabetic Neuropathy Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Diabetic Neuropathy Drugs Market Size Share by Regions (2019-2025)
Figure Global Diabetic Neuropathy Drugs Market Size Share by Regions in 2025
Figure United States Diabetic Neuropathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Diabetic Neuropathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Diabetic Neuropathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Diabetic Neuropathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Diabetic Neuropathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Diabetic Neuropathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Diabetic Neuropathy Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Diabetic Neuropathy Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Diabetic Neuropathy Drugs Market Size by Product (2019-2025)
Figure Global Diabetic Neuropathy Drugs Market Size by Product in 2025
Table Global Diabetic Neuropathy Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Diabetic Neuropathy Drugs Market Size by Application (2019-2025)
Figure Global Diabetic Neuropathy Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---